Up in smoke? With vaping on the edge of banishment, let our experts help with your coverage

Jul 7, 2022

4 min

The U.S. Food and Drug Administration (FDA) has paused a ban on the sale of Juul Labs' e-cigarettes, saying an additional review of the company's marketing application is required.


The once thriving company won a temporary reprieve a couple of weeks ago after a federal appeals court stayed the FDA's ban, following an appeal from Juul for an emergency review of the regulator's order.



Juul has always been in the spotlight, in part because of its prominent placement atop the e-cigarette chain, but with the company facing a potential demise, it could be the first casualty, with the rest of the vaping industry in the government's sights.


Dr. Zubair Karim, assistant professor in the Department of Interdisciplinary Health Sciences at Augusta University, fields a few questions and lends his expert perspective on this topic.



With the ban on Juul products, could this result in a ban on other companies’ e-cigarette products as well, or was there something specifically about Juul that caused their ban?


This is the first steps toward the banning of the e-cigarette, i.e., Juul, where the FDA took a significant and bold step. Gradually, this will open the path for banning of the other e-cigarette products. There are no differences in the Juul and other products but Juul became more popular in our young generation. Many local and state jurisdictions have recently begun enacting laws that prohibit e-cigarette usage that smoking is banned, although some state laws with comprehensive smoke-free laws will still allow for vaping to be permitted in bars and restaurants while prohibiting e-cigarettes in other indoor places.



On a more basic level, what are platelets (where are they, and what do they do) and do we know what has caused them to react more negatively compared to traditional smoking?


Platelets are small and colorless stem cell fragments present in our blood. They are disk-shaped and don’t have a nucleus. It plays an important role in maintaining vascular integrity based on their ability to respond to lesions in a vessel wall. Hyperactivity of platelets is known to cause spurious clot formation and occlusive loss of blood flow, leading to strokes and heart attacks, whereas hypoactivity causes bleeding diathesis with life-threatening consequences. Several studies have been reported that smoking induces oxidative stress, leading to increased platelet activation, whereas nicotine causes the damage of endothelial lining of the arterial and venous system and ultimately leads to the severe life-threatening consequences.


What are thrombotic events and why should someone be worried about them?


Thrombosis is the formation of a blood clot (partial or complete blockage) within blood vessels, whether venous or arterial, limiting the natural flow of blood. There are several complications depending on where the thrombosis is located. The most serious problems include stroke, heart attack and serious breathing problems, which is called pulmonary embolism. If the patients are not treated in a timely manner, it will lead to life-threatening conditions. However, progression of the disease can be prevented by following changes in our lifestyle such as increasing physical activity, quitting smoking, losing weight, eating a balanced diet, quitting junk food and managing other health conditions.



How do nicotine and other harmful chemical levels compare in vaping vs. traditional cigarettes?


Both smoking and vaping have similar side effects and cause serious health risks in the long run. Scientists do not fully understand the long-term health effects of electronic cigarettes (e-cigarettes), yet science indicates that they are not a safe alternative to smoking. In the last several years it has been observed that vaping is growing in popularity among teenagers. Moreover, e-cigarettes contain a large dose of nicotine, a substance known to slow the development of brains in fetuses, children and teens. Furthermore, vaping involves breathing in aerosol that contains several chemicals, including nicotine and flavoring through an e-cigarette or other devices. Also, the liquid present in the e-cigarettes which creates the vapor is dangerous to adults and children if they swallow, inhale, or get it on the skin. Nonetheless, vaping also delivers dangerous chemicals, including diacetyl, cancer-causing chemicals, heavy metals, volatile organic compounds (VOCs), and such toxic chemicals that are not generated in traditional cigarettes. In summary, long-term vaping causes similar toxic impact to overall health compared to traditional cigarettes.


This court case will be getting a lot of attention and could determine the future of the e-cigarette industry. If you're a journalist looking to know - then let Augusta University's expert help.


Karim is available to speak with reporters about vaping and e-cigarettes. Simply click on his icon now to arrange an interview today.

Powered by

You might also like...

Check out some other posts from Augusta University

When Science Can't Be Repeated: Tackling a Crisis in Research featured image

3 min

When Science Can't Be Repeated: Tackling a Crisis in Research

Science depends on a simple but critical principle: Research findings should be reliable enough that other researchers can reproduce them. But what happens when they can't? Biomedical research is confronting what has become known as the “reproducibility crisis,” with major scientific journals estimating that more than 80% of published biomedical research is negatively affected by defects that can make findings non-reproducible or unusable. Now, researchers at Augusta University are taking a closer look at why research goes wrong – and, more importantly, whether those problems can be prevented before findings are published. Backed by a new $2.5 million R01 grant from the National Institutes of Health, researchers in Augusta University's School of Public Health will identify common research defects and develop strategies to help scientists avoid them. The project is led by E. Andrew Balas, MD, PhD, a professor in the Department of Health Management, Economics, and Policy who has spent more than a decade studying the research process itself. “Research quality is not only a matter of detecting errors after they occur. The critical question is, how can we understand the conditions that produce research defects and develop effective ways to prevent them before they compromise scientific results?”  E. Andrew Balas, MD, PhD The consequences extend well beyond the laboratory. Unreliable findings can influence patient care, waste research funding and send other scientists down paths built on results that were never dependable. They can also contribute to something increasingly important for the scientific community: declining public trust. The Augusta University team plans to create a database of common research defects and examine which stages of the research process are particularly vulnerable. Researchers also envision a tool that could eventually allow scientists to enter information about their methodology and identify potential problems before completing and publishing their work. Wendy Burnett, PhD, an assistant professor in the School of Public Health and co-investigator on the study, summed up the stakes: “Years of work and substantial funding may be invested in studies based on results that were never dependable.”  Wendy Burnett, PhD The interdisciplinary project will also examine the human side of the problem, gathering perspectives from researchers, peer reviewers and journal editors to better understand why research defects happen and what may prevent people from recognizing or addressing them. Ultimately, the research asks a question that goes to the heart of modern science: How can we make research more trustworthy before mistakes become part of the scientific record? After the project is complete, Balas and his team hope the results will ultimately impact science and society in many significant ways. “Research has made wonders in our lives – we have life-saving drugs, we have a lifestyle that is healthier than ever before and so forth. If research could produce more valuable, useful, trustworthy, reproducible results, then we will all be better, and it should also increase public trust in research.” For media covering scientific integrity, biomedical research, public trust in science, research funding, peer review or the reproducibility crisis, this work offers a timely look at how the scientific community can improve not only what it discovers, but how those discoveries are made.

Cybersecurity Meets AI: Preparing the Next Generation for a New Kind of Digital Workforce featured image

3 min

Cybersecurity Meets AI: Preparing the Next Generation for a New Kind of Digital Workforce

Cybersecurity and artificial intelligence are rapidly becoming interconnected – creating new opportunities, new vulnerabilities and a growing need for professionals who understand both. At Augusta University, a new $2 million grant from the National Science Foundation will help prepare the next generation of professionals to work at that intersection. The School of Computer and Cyber Sciences received the award through the NSF’s Artificial Intelligence and Cybersecurity Education Innovation and Scholarship for Service Program. The funding will support Augusta University Government-Ready Experts in Resilient CyberAI, or AUGER CyberAI. Michael Nowatkowski, PhD, professor and director of Augusta University’s Cyber Institute and head of Cyber Programs of Study, is the project’s principal investigator. The program reflects a fundamental shift in cybersecurity education. AI can be used as a tool to strengthen cybersecurity, but AI technologies themselves must also be secured. Augusta University is responding by integrating more AI into its cybersecurity curriculum, rather than treating the two disciplines as entirely separate fields. Participating undergraduate, master’s and doctoral students will take at least four cybersecurity courses and two artificial intelligence courses. Students can receive up to three years of funding covering tuition and fees, along with annual stipends of $27,000 for undergraduate students and $37,000 for graduate students. In return, graduates will put those skills to work in public service, with participants required to work for a federal executive branch agency for the same number of years they receive funding. If federal employment is unavailable, the obligation can be fulfilled through state or local government employment. “As cybersecurity and artificial intelligence become more interconnected, we have a responsibility to prepare students with the knowledge and experience needed to meet the evolving needs of the workforce.” – Alex Schwarzmann, PhD Schwarzmann, dean of Augusta University’s School of Computer and Cyber Sciences, says AUGER CyberAI will allow the university to invest in students while mentoring a new generation of professionals prepared to serve the nation. The first cohort will begin in fall 2026, with approximately seven students expected in the inaugural group and another seven anticipated in 2027. Experts on Cybersecurity, AI and the Workforce Michael Nowatkowski is a leading cybersecurity expert whose areas of expertise include defensive cyber operations, cyber operations education, control system security, medical device security and information assurance. He can provide insight into how AI is changing cybersecurity, the skills future cyber professionals will require and how universities can prepare students for an evolving threat environment. View his profile Alex Schwarzmann is a nationally recognized expert in computer science, cybersecurity and distributed systems. His research has been supported by numerous grants from the National Science Foundation and other agencies, and he can provide perspective on computer science education, the changing technology workforce and the growing intersection between AI and cybersecurity.  View his profile For journalists covering artificial intelligence, cybersecurity, cyber threats, technology education, workforce development, government cybersecurity or the future of the technology workforce, Nowatkowski and Schwarzmann can provide expert analysis and perspective. If you’re interested in speaking with Michael Nowatkowski, PhD, or Alex Schwarzmann, PhD, about cybersecurity, artificial intelligence and preparing the next generation of cyber professionals, click on their profiles below.

A Silent Disease, a Surprising Discovery: Research Uncovers Chagas Risk in the U.S. featured image

2 min

A Silent Disease, a Surprising Discovery: Research Uncovers Chagas Risk in the U.S.

Chagas disease is often associated with Latin America, but new research from Augusta University is raising questions about how frequently the potentially serious infection may be going undiagnosed in the United States. Jose Vazquez, MD, division chief and professor of medicine in infectious diseases at the Medical College of Georgia at Augusta University, and his team recently tested farmworkers for antibodies associated with Chagas disease as part of a seroprevalence study. Of 155 blood specimens collected, 15 tested positive, a positivity rate of nearly 10%. The finding was particularly notable because Vazquez points to a recent study from Columbia and Greenville, South Carolina, that found a positivity rate of 2% to 3%. Chagas disease is caused by the parasite Trypanosoma cruzi and is found predominantly in Latin America. An estimated 240,000 to 350,000 people are infected in the United States. The disease can be especially difficult to identify because approximately 70% of cases are asymptomatic. When complications do develop, they can include serious cardiac and gastrointestinal problems. Dr. Jose Vazquez studies and treats infectious diseases, including COVID-19, antibiotic-resistant superbugs and fungal infections. View his profile Vazquez's interest in the disease became personal after someone he knew, originally from El Salvador, suffered cardiac arrest and was subsequently diagnosed with Chagas disease and severe cardiomyopathy. That experience helped prompt Vazquez to look more closely at the disease and its potential prevalence among populations in the region. “The reason why I’m doing it is twofold: One is if they’re positive, so we can treat them and maybe prevent these complications.” Jose Vazquez, MD For journalists covering Chagas disease, infectious diseases, health disparities, migrant and farmworker health, disease screening or emerging public health concerns in the United States, Vazquez can provide expert insight into what these findings mean and why greater awareness and screening may be important. Simply click on his profile now to arrange an interview today.

View all posts